Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 8, 2018Companies also announce submission of dupilumab supplemental BLA for uncontrolled, persistent asthma
-
Dec 13, 2017High and durable response rate in disease without any FDA-approved therapies
-
Dec 11, 2017* First FDA-approved follow-on mealtime insulin
-
Dec 7, 2017Phase 3 trials will evaluate isatuximab, an anti-CD38 antibody, in combination with other cancer treatments
